e-ISSN: Pending
Negative / Null Result ReportOpen accessMedicine· cited by 165

Advanced Intrahepatic Cholangiocarcinoma: Post Hoc Analysis of the ABC-01, -02, and -03 Clinical Trials

Ángela Lamarca; Paul J. Ross; Harpreet Wasan; Richard Hubner; Mairéad G. McNamara; Andre Lopes; Prakash Manoharan; Daniel G. Palmer · 2019 · JNCI Journal of the National Cancer Institute

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

BACKGROUND: The incidence of intrahepatic cholangiocarcinoma (iCCA) is increasing. The aim of the study was to provide reference survival data for patients with advanced iCCA treated with first-line cisplatin-gemcitabine chemotherapy (current standard of care). METHODS: Individual data from patients with iCCA recruited into the prospective, random assignment Advanced Biliary Tract Cancer (ABC)-01, -02, and -03 studies were retrieved. The prevalence and survival of liver-only iCCA was also assessed. Survival analysis was performed using univariate and multivariable Cox regression. All statistic

Abstract by Ángela Lamarca; Paul J. Ross; Harpreet Wasan; Richard Hubner; Mairéad G. McNamara; Andre Lopes; Prakash Manoharan; Daniel G. Palmer, JNCI Journal of the National Cancer Institute (2019) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.1093/jnci/djz071